2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Mishraki-Berkowitz T et al. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase. 2017 J Colloid Interface Sci pmid:27701016
Ruela AL et al. Exploring the Phase Behavior of Monoolein/Oleic Acid/Water Systems for Enhanced Donezepil Administration for Alzheimer Disease Treatment. 2016 J Pharm Sci pmid:26852841
Rossetti FC et al. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. 2016 Eur J Pharm Sci pmid:26657201
Gonçalves VSS et al. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs. 2016 Int J Pharm pmid:27702697
Shi C et al. Exploring the effect of hydrophilic and hydrophobic structure of grafted polymeric micelles on drug loading. 2016 Int J Pharm pmid:27576669
Carneiro C et al. Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. 2016 Acta Biomater pmid:27150234
Oka T et al. Activation Energy of the Low-pH-Induced Lamellar to Bicontinuous Cubic Phase Transition in Dioleoylphosphatidylserine/Monoolein. 2016 Langmuir pmid:26766583
Mazzoni S et al. Cytochrome-c Affects the Monoolein Polymorphism: Consequences for Stability and Loading Efficiency of Drug Delivery Systems. 2016 Langmuir pmid:26710233
Patil SS et al. Fabrication of novel GMO/Eudragit E100 nanostructures for enhancing oral bioavailability of carvedilol. 2016 Drug Dev Ind Pharm pmid:26651381
Kolev V et al. Unit cell structure of water-filled monoolein in inverted hexagonal mesophase in the presence of incorporated tricaprylin and entrapped lysozyme. 2016 Eur. Biophys. J. pmid:26424533
Lopes I et al. Monoolein-based nanocarriers for enhanced folate receptor-mediated RNA delivery to cancer cells. 2016 J Liposome Res pmid:26340109
Yu X et al. Melanoma therapy with transdermal mitoxantrone cubic phases. 2016 Drug Deliv pmid:25835224
Ikeda I et al. Resistant Maltodextrin Decreases Micellar Solubility of Lipids and Diffusion of Bile Salt Micelles and Suppresses Incorporation of Micellar Fatty Acids into Caco-2 Cells. 2016 J. Nutr. Sci. Vitaminol. pmid:27928121
Shen J et al. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex. 2016 Int J Nanomedicine pmid:27713630
Freag MS et al. Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. 2016 Int J Nanomedicine pmid:27703348
Peng X et al. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. 2015 Drug Des Devel Ther pmid:26345516
Reese CW et al. Structural insights into the cubic-hexagonal phase transition kinetics of monoolein modulated by sucrose solutions. 2015 Phys Chem Chem Phys pmid:25758637
Milak S and Zimmer A Glycerol monooleate liquid crystalline phases used in drug delivery systems. 2015 Int J Pharm pmid:25479099
Sato H et al. Physicochemical stability study on cyclosporine A loaded dry-emulsion formulation with enhanced solubility. 2015 Chem. Pharm. Bull. pmid:25743195
Patil SS et al. Liquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug delivery. 2015 Eur J Pharm Sci pmid:25460546